|
| The significance of ovarian fibrosis |
|
https://doi.org/10.18632/oncotarget.27822
David A. Landry, Het T. Vaishnav, Barbara C. Vanderhyden
|
| 4366-4370 |
|
| Treatment of elderly patients with refractory/relapsed multiple myeloma: oral drugs adherence and the COVID-19 outbreak |
|
https://doi.org/10.18632/oncotarget.27819
Flávia Dias Xavier, Fernando Sergio Blumm Ferreira, Rodrigo Martins Abreu
|
| 4371-4386 |
|
| Selective amplification of hypermethylated DNA from diverse tumor types via MSRE-PCR |
|
https://doi.org/10.18632/oncotarget.27825
Karen B. Chapman, Brandon W. Higgs
|
| 4387-4400 |
|
| Predictors of immunotherapy benefit in Merkel cell carcinoma |
|
https://doi.org/10.18632/oncotarget.27823
Alec J. Kacew, Harita Dharaneeswaran, Gabriel J. Starrett, Manisha Thakuria, Nicole R. LeBoeuf, Ann W. Silk, James A. DeCaprio, Glenn J. Hanna
|
| 4401-4410 |
|
| Cytogenetic and molecular landscape and its potential clinical significance in Hispanic CMML patients from Puerto Rico |
|
https://doi.org/10.18632/oncotarget.27824
Zeju Jiang, Xinlai Sun, Zhao Wu, Albert Alhatem, Ruifang Zheng, Dongfang Liu, Yaqun Wang, Dibyendu Kumar, Changqing Xia, Bei You, He Wang, Chen Liu, Jie-Gen Jiang
|
| 4411-4420 |
|
| Ibuprofen disrupts a WNK1/GSK3β/SRPK1 protein complex required for expression of tumor-related splicing variant RAC1B in colorectal cells |
|
https://doi.org/10.18632/oncotarget.27816
Vânia Gonçalves, Andreia F.A. Henriques, Paulo Matos, Peter Jordan
|
| 4421-4437 |
|
| Effect of liver fibrosis on survival in patients with intrahepatic cholangiocarcinoma: a SEER population-based study |
|
https://doi.org/10.18632/oncotarget.27820
Nimrod Adatto Levy, Guy Kern, Daniel Shepshelovich, Oren Shibolet, Rami Hershkoviz, Ofer Isakov
|
| 4438-4447 |
|
| Reduced CpG island methylation of the TBC1D8 gene may predict risk for osteoporosis in Chinese postmenopausal women |
|
https://doi.org/10.18632/oncotarget.24065
|
| 4448-4456 |
|
| A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial |
|
https://doi.org/10.18632/oncotarget.27807
Guillermo de Velasco, Lucia Carril-Ajuria, Felix Guerrero-Ramos, Teresa Alonso-Gordoa, Juan F. Rodríguez-Moreno, Alberto Carretero, Maricruz Martin-Soberon, Federico de la Rosa-Kehrmann, Daniel Castellano
|
| 4457-4462 |
